Fort Washington Investment Advisors Inc. OH Cuts Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Fort Washington Investment Advisors Inc. OH cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,380 shares of the financial services provider’s stock after selling 150 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in iShares Biotechnology ETF were worth $711,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in IBB. BNP Paribas Financial Markets raised its position in iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its position in iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the period. Aprio Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth about $18,476,000. Aristides Capital LLC bought a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $9,180,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $8,118,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $138.25 on Friday. The company’s 50 day moving average is $135.97 and its 200-day moving average is $141.78. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.